Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsThe Lancet infectious diseases, 2021-08, Vol.21 (8), p.1107-1119 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00127-4 ;PMID: 33773111Full text available |
|
2 |
Material Type: Article
|
Malaria Vaccines: Recent Advances and New HorizonsCell host & microbe, 2018-07, Vol.24 (1), p.43-56 [Peer Reviewed Journal]2018 The Author(s) ;Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved. ;2018 The Author(s) 2018 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.06.008 ;PMID: 30001524Full text available |
|
3 |
Material Type: Article
|
The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen IdentificationClinical cancer research, 2021-02, Vol.27 (3), p.689-703 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-20-0245 ;PMID: 33122346Full text available |
|
4 |
Material Type: Article
|
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or OlderThe New England journal of medicine, 2016-09, Vol.375 (11), p.1019-1032 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603800 ;PMID: 27626517Full text available |
|
5 |
Material Type: Article
|
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in miceNature communications, 2021-01, Vol.12 (1), p.372-372, Article 372 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20653-8 ;PMID: 33446655Full text available |
|
6 |
Material Type: Article
|
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesThe Journal of experimental medicine, 2018-06, Vol.215 (6), p.1571-1588 [Peer Reviewed Journal]2018 Pardi et al. ;Copyright Rockefeller University Press Jun 4, 2018 ;2018 Pardi et al. 2018 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20171450 ;PMID: 29739835Full text available |
|
7 |
Material Type: Article
|
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older AdultsThe New England journal of medicine, 2015-05, Vol.372 (22), p.2087-2096 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501184 ;PMID: 25916341Full text available |
|
8 |
Material Type: Article
|
Structure-based programming of lymph-node targeting in molecular vaccinesNature (London), 2014-03, Vol.507 (7493), p.519-522 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Mar 27, 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature12978 ;PMID: 24531764 ;CODEN: NATUASFull text available |
|
9 |
Material Type: Article
|
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2021-02, Vol.397 (10275), p.682-694 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00241-5 ;PMID: 33524311Full text available |
|
10 |
Material Type: Article
|
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunityNature (London), 2022-01, Vol.601 (7894), p.617-622 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Jan 27, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04232-5 ;PMID: 34814158Full text available |
|
11 |
Material Type: Article
|
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccinesCell research, 2021-07, Vol.31 (7), p.732-741 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-021-00514-9 ;PMID: 34021265Full text available |
|
12 |
Material Type: Article
|
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severityScience, 2021-02, Vol.371 (6532) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc8378Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Vaccine protection against Zika virus from BrazilNature (London), 2016-08, Vol.536 (7617), p.474-478 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 25, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature18952 ;PMID: 27355570 ;CODEN: NATUASFull text available |
|
14 |
Material Type: Article
|
In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseasesScientific reports, 2019-03, Vol.9 (1), p.4409-4409, Article 4409 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-40833-x ;PMID: 30867498Full text available |
|
15 |
Material Type: Article
|
Emerging Concepts and Technologies in Vaccine DevelopmentFrontiers in immunology, 2020-09, Vol.11, p.583077 [Peer Reviewed Journal]Copyright © 2020 Brisse, Vrba, Kirk, Liang and Ly. ;Copyright © 2020 Brisse, Vrba, Kirk, Liang and Ly 2020 Brisse, Vrba, Kirk, Liang and Ly ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.583077 ;PMID: 33101309Full text available |
|
16 |
Material Type: Article
|
Vaccine Mediated Protection Against Zika Virus-Induced Congenital DiseaseCell, 2017-07, Vol.170 (2), p.273-283.e12 [Peer Reviewed Journal]2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2017.06.040 ;PMID: 28708997Full text available |
|
17 |
Material Type: Article
|
Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infectionScientific reports, 2017-08, Vol.7 (1), p.9232-13, Article 9232 [Peer Reviewed Journal]2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-09199-w ;PMID: 28835708Full text available |
|
18 |
Material Type: Article
|
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case studyScientific reports, 2021-02, Vol.11 (1), p.3238-21, Article 3238 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-81749-9 ;PMID: 33547334Full text available |
|
19 |
Material Type: Article
|
The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE3Leiden.CETP miceEuropean heart journal, 2017-08, Vol.38 (32), p.2499-2507 [Peer Reviewed Journal]The Author 2017. Published on behalf of the European Society of Cardiology. ;The Author 2017. Published on behalf of the European Society of Cardiology. 2017 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehx260 ;PMID: 28637178Full text available |
|
20 |
Material Type: Article
|
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or OlderThe Journal of infectious diseases, 2018-05, Vol.217 (11), p.1750-1760 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. 2018 ;ISSN: 0022-1899 ;ISSN: 1537-6613 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiy095 ;PMID: 29529222Full text available |